14Feb
14Feb
Windgap Medical Appoints Aaron Mann as CEO, Michael Samar as CFO
Windgap Medical announced today it has appointed Aaron Mann as the company's Chief Executive Officer and Michael Samar as the company's Chief Financial Officer, effective February 1. Both bring significant industry tenure and experience to their roles, and with Windgap Co-Founder Brent Buchine, will lead the company's continued growth in the field of complex injectable drug delivery solutions. "Aaron Mann brings a depth of industry experience that is a strong complement to the scientific and technical team in place today...
13Feb
Matchmaking service Tawkify picks up ‘anti-superficial’ dating app S’More in mobile expansion
Matchmaking service provider Tawkify announced today it acquired S’More, an “anti-superficial” dating app that had experimented with blurred profile photos, and even blurred video chats, in an attempt to get people to get to know one another without the focus on physical appearance. With the acquisition, S’More is sunsetting its app, and founder Adam Cohen-Aslatei will instead join the Tawkify team to lead the launch of its first-ever mobile product. Deal terms were not disclosed, but S’More had raised
09Feb
EarthGrid, PBC Wins ‘Most Fundable Company’ Award from Pepperdine Graziadio Business School
EarthGrid, PBC is excited to announce that it won Platinum recognition — the highest honor — on the Pepperdine Graziadio Business School’s fifth annual Most Fundable Companies® List. EarthGrid competed against 4,000-plus early-stage U.S. companies before earning a coveted Platinum spot among 16 finalists. The Most Fundable Companies initiative educates on the investor diligence process and recognizes exceptional entrepreneurs who are solving problems with inventive solutions and are also seeking investment capital. Watch EarthGrid’s presentation. Troy Helming, Founder and CEO...
09Feb
4 reasons why it matters to replace our plastic cutlery with biodegradable one as a path to sustainability
Biodegradable cutlery that is predominantly resourced from natural materials like corn starch, sugarcane, or bamboo decomposes quickly and necessitates no chemical usage during the entire manufacturing process. “Disposable plastic products have posed a detrimental impact on the environment for decades now, with estimates showing that around nine million metric tonnes of plastic end up in the ocean each year. Hence, plastic disposables are not a viable long-term solution, as plastic makes up more than 80% of marine litter, and 70%...
07Feb
MyoPro Approved in Australia by National Disability Insurance Scheme
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, announced that for the first time, the National Disability Insurance Scheme (NDIS) in Australia approved a MyoPro for a patient with a paralyzed arm. The NDIS aids over 500,000 Australians with disabilities through reimbursement for necessary services and support. The patented MyoPro technology was developed by Myomo in collaboration with researchers at the Massachusetts Institute of Technology and Harvard Medical...
31Jan
Myomo Appoints Yitzchak Jacobovitz to its Board of Directors
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced the appointment of Yitzchak Jacobovitz as a Class II director effective January 27, 2023, to serve until the 2025 annual meeting of stockholders. With this appointment, Myomo has six directors. “We welcome Yitz to the Myomo Board of Directors and are gratified that AIGH was the lead investor in our most recent equity offering,” said Paul R. Gudonis,...
28Jan
Immusoft Awarded $8M in Funding from the California Institute for Regenerative Medicine (CIRM) for MPS I Clinical Program
Immusoft of CA, a wholly owned subsidiary of Immusoft Corporation, a clinical-stage cell therapy company dedicated to improving the lives of patients with rare or genetic diseases, announced today that the California Institute for Regenerative Medicine (CIRM) has awarded the company an $8M grant. This funding will support a Phase I study to evaluate the safety and tolerability of ISP-001 (for delivery of alpha-L-iduronidase, or IDUA) in MPS I a rare, childhood genetic disease. The Investigational New Drug Application for...
24Jan
Researchers confirm successful rehabilitation and recovery of human donor lungs previously deemed unfit for transplant
A novel method for supporting and recovering donor lungs outside the body shows potential to increase the number of organs available for transplant, according to a recent study published in The Journal of Heart and Lung Transplantation. The organ shortage crisis is increasingly dire, as thousands of patients die every year waiting to receive donor organs. Despite urgent demand, nearly 80% of donated lungs are too damaged for transplantation, often due to reversible conditions. A cross-disciplinary team of surgeons and...
24Jan